Mouse Models of Stargardt 3 Dominant Macular Degeneration

  • Peter Barabas
  • Aruna Gorusupudi
  • Paul S Bernstein
  • David Krizaj
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 854)

Abstract

Stargardt type 3 macular degeneration is dependent on a dominant defect in a single gene, ELOVL4 (elongase of very long chain fatty acids 4). The encoded enzyme, ELOVL4, is required for the synthesis of very long chain polyunsaturated fatty acids (VLC-PUFAs), a rare class of > C24 lipids. In vitro expression studies suggest that mutated ELOVL4STGD3 proteins fold improperly, resulting in ER stress and formation of cytosolic aggresomes of wild type and mutant ELOVL4. Although a number of mouse models have been developed to determine whether photoreceptor cell loss in STGD3 results from depletion of VLC-PUFAs, aggresome-dependent cell stress or a combination of these two factors, none of these models adequately recapitulates the disease phenotype in humans. Thus, the precise molecular mechanism by which ELOVL4 mutation causes photoreceptor degeneration in mice and in human patients remains to be characterized. This mini review compares and evaluates current STGD3 mouse models and determines what conclusions can be drawn from past work.

Keywords

ELOVL4 STGD3 Very long chain polyunsaturated fatty acids (VLC-PUFAs) Transgenic mice Knock-in mice Knock-out mice pLox Cre Phenotype 

References

  1. Agbaga MP, Brush RS, Mandal MN et al (2008) Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci U S A 105:12843–12848CrossRefPubMedPubMedCentralGoogle Scholar
  2. Agbaga MP, Tam BM, Wong JS (2014) Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks. Invest Ophthalmol Vis Sci 55:3669–3680CrossRefPubMedPubMedCentralGoogle Scholar
  3. Ambasudhan R, Wang X, Jablonski MM et al (2004) Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Genomics 83:615–625CrossRefPubMedGoogle Scholar
  4. Barabas P, Liu A, Xing W et al (2013) Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration. Proc Natl Acad Sci U S A 110:5181–5186CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bennett LD, Brush RS, Chan M et al (2014a) Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors. Invest Ophthalmol Vis Sci 55:3150–3157CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bennett LD, Hopiavuori BR, Brush RS et al (2014b) Examination of VLC-PUFA-deficient photoreceptor terminals. Invest Ophthalmol Vis Sci 55:4063–4072CrossRefPubMedPubMedCentralGoogle Scholar
  7. Bernstein PS, Tammur J, Singh N et al (2001) Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci 42:3331–3336PubMedGoogle Scholar
  8. Grayson C, Molday RS (2005) Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. J Biol Chem 280:32521–32530CrossRefPubMedGoogle Scholar
  9. Guillou H, Zadravec D, Martin PG et al (2010) The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Prog Lipid Res 49:186–199CrossRefPubMedGoogle Scholar
  10. Harkewicz R, Du H, Tong Z et al (2012) Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function. J Biol Chem 287:11469–11480CrossRefPubMedPubMedCentralGoogle Scholar
  11. Hubbard AF, Askew EW, Singh N et al (2006) Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation. Arch Ophthalmol 124:257–263CrossRefPubMedPubMedCentralGoogle Scholar
  12. Karan G, Lillo C, Yang Z et al (2005) Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A 102:4164–4169CrossRefPubMedPubMedCentralGoogle Scholar
  13. Kuny S, Gaillard F, Mema SC et al (2010) Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3). Invest Ophthalmol Vis Sci 51:2248–2262CrossRefPubMedPubMedCentralGoogle Scholar
  14. Kuny S, Gaillard F, Sauvé Y (2012) Differential gene expression in eyecup and retina of a mouse model of Stargardt-like macular dystrophy (STGD3). Invest Ophthalmol Vis Sci 53:664–675CrossRefPubMedGoogle Scholar
  15. Le YZ, Zheng L, Zheng W et al (2006) Mouse opsin promoter-directed Cre recombinase expression in transgenic mice. Mol Vis 12:389–398.PubMedGoogle Scholar
  16. Li W, Chen Y, Cameron DJ et al (2007) Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Vis Res 47:714–722CrossRefPubMedPubMedCentralGoogle Scholar
  17. Lin JH, Lavail MM (2010) Misfolded proteins and retinal dystrophies. Adv Exp Med Biol. 664:115–121CrossRefPubMedPubMedCentralGoogle Scholar
  18. Lin JH, Walter P, Yen TS (2008) Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol 3:399–425CrossRefPubMedPubMedCentralGoogle Scholar
  19. Liu A, Chang J, Lin Y et al (2010) Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res 51:3217–3229CrossRefPubMedPubMedCentralGoogle Scholar
  20. Liu A, Terry R, Lin Y et al (2013) Comprehensive and sensitive quantification of long-chain and very long-chain polyunsaturated fatty acids in small samples of human and mouse retina. J Chromatogr A 1307:191–200CrossRefPubMedGoogle Scholar
  21. Logan S, Agbaga MP, Chan MD et al (2013) Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy. Proc Natl Acad Sci U S A 110:5446–5451CrossRefPubMedPubMedCentralGoogle Scholar
  22. Logan S, Agbaga MP, Chan MD et al (2014) Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity. J Lipid Res 55:698–708CrossRefPubMedPubMedCentralGoogle Scholar
  23. Mandal NA, Tran JT, Zheng L et al (2014) In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4. Invest Ophthalmol Vis Sci 55:2705–2713CrossRefPubMedPubMedCentralGoogle Scholar
  24. Marchette LD, Sherry DM, Brush RS et al (2014) Very long chain polyunsaturated fatty acids and rod cell structure and function. Adv Exp Med Biol 801:637–645CrossRefPubMedPubMedCentralGoogle Scholar
  25. McMahon A, Kedzierski W (2010) Polyunsaturated very-long-chain C28-C36 fatty acids and retinal physiology. Br J Ophthalmol 94:1127–1132CrossRefPubMedGoogle Scholar
  26. McMahon A, Jackson SN, Woods AS et al (2007) A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines. FEBS Lett 581:5459–5463CrossRefPubMedPubMedCentralGoogle Scholar
  27. Raz-Prag D, Ayyagari R, Fariss RN et al (2006) Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease. Invest Ophthalmol Vis Sci 47:3603–3611CrossRefPubMedPubMedCentralGoogle Scholar
  28. SanGiovanni JP, Chew EY (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24:87–138CrossRefPubMedGoogle Scholar
  29. Vasireddy V, Jablonski MM, Mandal MN et al (2006) Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration. Invest Ophthalmol Vis Sci 47:4558–4568CrossRefPubMedGoogle Scholar
  30. Vasireddy V, Uchida Y, Salem N Jr. et al (2007) Loss of functional ELOVL4 depletes very long-chain fatty acids (> or = C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum Mol Genet 16:471–482CrossRefPubMedPubMedCentralGoogle Scholar
  31. Vasireddy V, Wong P, Ayyagari R (2010) Genetics and molecular pathology of Stargardt-like macular degeneration. Prog Retin Eye Res 29:191–207CrossRefPubMedPubMedCentralGoogle Scholar
  32. Zemski Berry KA, Gordon WC, Murphy RC et al (2014) Spatial organization of lipids in the human retina and optic nerve by MALDI imaging mass spectrometry. J Lipid Res 55:504–515CrossRefPubMedPubMedCentralGoogle Scholar
  33. Zhang K, Kniazeva M, Han M et al (2001) A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27:89–93PubMedGoogle Scholar
  34. Zhang XM, Yang Z, Karan G et al (2003) Elovl4 mRNA distribution in the developing mouse retina and phylogenetic conservation of Elovl4 genes. Mol Vis 9:301–307PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Peter Barabas
    • 1
  • Aruna Gorusupudi
    • 1
  • Paul S Bernstein
    • 1
  • David Krizaj
    • 1
  1. 1.Department of Ophthalmology and Visual Sciences, John A. Moran Eye InstituteUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations